LONDON, UK, 3 October 2008 - SkyePharma PLC (LSE: SKP) ("SkyePharma" or the "Company") today announces that the new terms for the 2024 and 2025 convertible bonds are now effective which successfully completes the Transactions announced on 1 September.
